Leggett & Platt (NYSE:LEG) Stock, Quote.Headers.trade-ideas

Leggett & Platt

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

xr:d:DAFyYXXrqcs:2,j:4471355769042698728,t:23102617

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CTRN

Insiders Buying Norfolk Southern And 3 Other Stocks

Stocks Photo by WHYFRAME on Shutterstock

IART

$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Market,Sentiment,,Fear,And,Greed,Index,,Emotional,On,Stock,Market

AAPL

AMZN

Investor Optimism Improves Slightly Following Fed Decision

Leggett & Platt, Incorporated Common Stock

Leggett & Platt Inc

Legacy Housing Corporation - Common Stock

Legacy Housing Corp

LEG IMMOBILIEN SE ON by Leg Immobilien SE

LEG Immobilien SE

Legend Biotech Corporation - American Depositary Shares

Legend Biotech Corp

FIRST TRUST INNOVATIVE TECH UCITS ETF

First Trust Indxx Innovative Transaction & Process ETF

Legato Merger Corp III

Legato Merger Corp. III Units, each consisting of one Ordinary Share and one-half of one warrant

Legato Merger Corp. III Redeemable Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share

Legato Merger Corp. III

Truist Securities analyst Keith Hughes maintains Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) with a Hold and raises the price target from $11 to $13.

Price Target

Analyst Ratings

Truist Securities Maintains Hold on Leggett & Platt, Raises Price Target to $13

Guidance

Leggett & Platt Sees FY24 Adj. EPS $1.10-$1.25 Vs $1.11 Est.; Sales $4.3B-$4.5B Vs $4.424B Est.

Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.30 by 3.33 percent. The company reported quarterly sales of $1.128 billion which missed the analyst consensus estimate of $1.134 billion by 0.54 percent. This is a 7.62 percent decrease over sales of $1.221 billion the same period last year.

Earnings

Earnings Misses

Leggett & Platt Q2 2024 Adj. EPS $0.29 Misses $0.30 Estimate, Sales $1.128B Miss $1.134B Estimate

Goldman Sachs analyst Susan Maklari maintains Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) with a Neutral and lowers the price target from $14 to $12.

Goldman Sachs Maintains Neutral on Leggett & Platt, Lowers Price Target to $12

Throughout the last three months, 4 analysts have evaluated Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Leggett &amp; Platt, presenting an average target of $12.75, a high estimate of $14.00, and a low estimate of $11.00. A decline of 21.54% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1719496815_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Leggett &amp; Platt's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$11.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Susan Maklari</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Leggett &amp; Platt. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Leggett &amp; Platt compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Leggett &amp; Platt's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Leggett &amp; Platt's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LEG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Leggett &amp; Platt analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Leggett &amp; Platt's Background</h2>
Leggett &amp; Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett &amp; Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
<h3>Leggett &amp; Platt: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Leggett &amp; Platt's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -9.62% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Leggett &amp; Platt's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.88% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.41%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Leggett &amp; Platt's ROA excels beyond industry benchmarks, reaching 0.68%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.78.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 4 Analyst Recommendations For Leggett & Platt

Truist Securities analyst Keith Hughes maintains Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) with a Hold and lowers the price target from $13 to $11.

Truist Securities Maintains Hold on Leggett & Platt, Lowers Price Target to $11

Offerings

Leggett & Platt Inc Files For Mixed Shelf Offering; Size Not Disclosed

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Citi Trends</h3>
<ul>
<li>The Trade: Citi Trends, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) 10% owner Pleasant Lake Partners LLC <a href="https://www.benzinga.com/quote/CTRN/analyst-ratings">acquired a total of 32,508 shares</a> at an average price of $24.69. To acquire these shares, it cost around $802,617.</li>
<li>What's Happening: On June 4, Citi Trends reported mixed first-quarter results and revised full year 2024 outlook.</li>
<li>What Citi Trends Does: Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States.</li>
</ul>
<h3 class="wp-block-heading">Norfolk Southern</h3>
<ul>
<li>The Trade: Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) Director Sameh Fahmy acquired a total of 2,000 shares at an average price of $222.18. To acquire these shares, it cost around $444,355.</li>
<li>What's Happening: On May 23, Norfolk Southern reached an agreement to resolve federal East Palestine derailment claims and investigations.</li>
<li>What Norfolk Southern Does: Class-I railroad Norfolk Southern operates in the Eastern United States. On more than 20,000 miles of track, the rail hauls shipments of coal, intermodal traffic, and a diverse mix of automobile, agriculture, metal, chemical, and forest products.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">SLM</h3>
<ul>
<li>The Trade: SLM Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) Director Richard Scott Blackley <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 11,702 shares</a> at an average price of $21.31. To acquire these shares, it cost around $249,378.</li>
<li>What's Happening: On June 4, TD Cowen analyst Moshe Orenbuch maintained SLM with a Buy and raised the price target from $25 to $27.</li>
<li>What SLM Does: SLM Corp is the largest student lender in the country.</li>
</ul>
<h3 class="wp-block-heading">Leggett &amp; Platt</h3>
<ul>
<li>The Trade: Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) EVP &#8211; General Counsel Jennifer Joy Davis <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,985 shares</a> at an average price of $12.50. The insider spent around $24,812 to buy those shares.</li>
<li>What's Happening: On May 21, Leggett &amp; Platt named Karl Glassman as President and CEO.</li>
<li>What Leggett &amp; Platt Does: Leggett &amp; Platt Inc designs and produces engineered components and products found in homes and automobiles.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/06/39157943/top-3-tech-and-telecom-stocks-you-may-want-to-dump-in-june">Top 3 Tech And Telecom Stocks You May Want To Dump In June</a>

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/31/24</td>
<td>$175.00</td>
<td>$26.2K</td>
<td>10.8K</td>
<td>76.5K</td>
</tr>
<tr>
<td>RCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/31/24</td>
<td>$148.00</td>
<td>$40.4K</td>
<td>1.2K</td>
<td>978</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$100.00</td>
<td>$53.3K</td>
<td>10.7K</td>
<td>974</td>
</tr>
<tr>
<td>GPC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$140.00</td>
<td>$414.6K</td>
<td>24</td>
<td>347</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$170.00</td>
<td>$98.8K</td>
<td>1.9K</td>
<td>169</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$5.00</td>
<td>$27.4K</td>
<td>24.6K</td>
<td>167</td>
</tr>
<tr>
<td>LEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$10.00</td>
<td>$26.8K</td>
<td>386</td>
<td>153</td>
</tr>
<tr>
<td>ABNB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$140.00</td>
<td>$93.4K</td>
<td>1.6K</td>
<td>141</td>
</tr>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$25.00</td>
<td>$26.7K</td>
<td>4.2K</td>
<td>74</td>
</tr>
<tr>
<td>ASO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$65.00</td>
<td>$64.2K</td>
<td>419</td>
<td>61</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 200 contract(s) at a $175.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.2K, with a price of $131.0 per contract. There were 10813 open contracts at this strike prior to today, and today 76505 contract(s) were bought and sold. 
• For RCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), we notice a put option sweep that happens to be bearish, is expiring today. Parties traded 155 contract(s) at a $148.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $40.4K, with a price of $261.0 per contract. There were 1221 open contracts at this strike prior to today, and today 978 contract(s) were bought and sold. 
• Regarding BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we observe a call option trade with bullish sentiment. It expires in 203 day(s) on December 20, 2024. Parties traded 199 contract(s) at a $100.00 strike. The total cost received by the writing party (or parties) was $53.3K, with a price of $268.0 per contract. There were 10763 open contracts at this strike prior to today, and today 974 contract(s) were bought and sold. 
• For GPC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>), we notice a call option trade that happens to be bullish, expiring in 203 day(s) on December 20, 2024. This event was a transfer of 347 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $414.6K, with a price of $1195.0 per contract. There were 24 open contracts at this strike prior to today, and today 347 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a put option sweep with bearish sentiment. It expires in 140 day(s) on October 18, 2024. Parties traded 113 contract(s) at a $170.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $98.8K, with a price of $875.0 per contract. There were 1913 open contracts at this strike prior to today, and today 169 contract(s) were bought and sold. 
• Regarding NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), we observe a call option sweep with bullish sentiment. It expires in 321 day(s) on April 17, 2025. Parties traded 150 contract(s) at a $5.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $27.4K, with a price of $183.0 per contract. There were 24658 open contracts at this strike prior to today, and today 167 contract(s) were bought and sold. 
• Regarding LEG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>), we observe a call option sweep with bullish sentiment. It expires in 21 day(s) on June 21, 2024. Parties traded 150 contract(s) at a $10.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $26.8K, with a price of $178.0 per contract. There were 386 open contracts at this strike prior to today, and today 153 contract(s) were bought and sold. 
• Regarding ABNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), we observe a put option sweep with bullish sentiment. It expires in 112 day(s) on September 20, 2024. Parties traded 119 contract(s) at a $140.00 strike. This particular put needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $93.4K, with a price of $785.0 per contract. There were 1684 open contracts at this strike prior to today, and today 141 contract(s) were bought and sold. 
• For CHWY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>), we notice a put option sweep that happens to be bearish, expiring in 231 day(s) on January 17, 2025. This event was a transfer of 45 contract(s) at a $25.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $26.7K, with a price of $595.0 per contract. There were 4253 open contracts at this strike prior to today, and today 74 contract(s) were bought and sold. 
• For ASO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>), we notice a put option trade that happens to be bullish, expiring in 231 day(s) on January 17, 2025. This event was a transfer of 60 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $64.2K, with a price of $1070.0 per contract. There were 419 open contracts at this strike prior to today, and today 61 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ABNB

BABA

CHWY

TSLA

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Integra LifeSciences Holdings</h3>
<ul>
<li>The Trade: Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) Director, Exec. Chairman of the Board Stuart Essig <a href="https://www.benzinga.com/quote/IART/analyst-ratings">acquired a total of 52,641 shares</a> at an average price of $28.49. To acquire these shares, it cost around $1.5 million.</li>
<li>What's Happening: On May 6, Integra LifeSciences reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus of $361.96 million and the management guidance of $360 million to $365 million.</li>
<li>What Integra LifeSciences Holdings Does: Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications.</li>
</ul>
<h3 class="wp-block-heading">Manitowoc Company</h3>
<ul>
<li>The Trade: The Manitowoc Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTW#NYSE">MTW</a>) EVP &amp; Chief Financial Officer Brian P Regan acquired a total of 1,000 shares at an average price of $12.21. To acquire these shares, it cost around $12,210.</li>
<li>What's Happening: On May 7, Manitowoc reported weak first-quarter earnings.</li>
<li>What Manitowoc Company Does: Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">Leggett &amp; Platt</h3>
<ul>
<li>The Trade: Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) Director Mark A Blinn <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 6,000 shares</a> at an average price of $10.74. To acquire these shares, it cost around $64,439.</li>
<li>What's Happening: On May 21, Leggett &amp; Platt named Karl Glassman as President and CEO.</li>
<li>What Leggett &amp; Platt Does: Leggett &amp; Platt Inc designs and produces engineered components and products found in homes and automobiles.</li>
</ul>
<h3 class="wp-block-heading">Wabash National</h3>
<ul>
<li>The Trade: Wabash National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNC#NYSE">WNC</a>) Director John G. Boss <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 3,658 shares</a> at an average price of $16.45. The insider spent around $60,163 to buy those shares.</li>
<li>What's Happening: On May 21, the company declared a regular quarterly dividend of 8 cents per share of the company&#8217;s common stock.</li>
<li>What Wabash National Does: Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/39006627/top-3-materials-stocks-that-are-set-to-fly-this-quarter">Top 3 Materials Stocks That Are Set To Fly This Quarter</a>

Leggett &amp; Platt's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) short percent of float has fallen 12.33% since its last report. The company recently reported that it has 8.30 million shares sold short, which is 7.25% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.44 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Leggett &amp; Platt Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715006716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Leggett &amp; Platt has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Leggett &amp; Platt's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Leggett &amp; Platt's peer group average for short interest as a percentage of float is 6.62%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Leggett & Platt's Recent Short Interest

Truist Securities analyst Keith Hughes maintains Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) with a Hold and lowers the price target from $16 to $13.

Truist Securities Maintains Hold on Leggett & Platt, Lowers Price Target to $13

Throughout the last three months, 5 analysts have evaluated Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Leggett &amp; Platt, revealing an average target of $15.4, a high estimate of $18.00, and a low estimate of $13.00. A decline of 19.79% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1714680024_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Leggett &amp; Platt by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Susan Maklari</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$18.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Leggett &amp; Platt. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Leggett &amp; Platt compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Leggett &amp; Platt's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LEG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Leggett &amp; Platt analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Leggett &amp; Platt Better</h2>
Leggett &amp; Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett &amp; Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
<h3>Breaking Down Leggett &amp; Platt's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Challenges: Leggett &amp; Platt's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -1.63%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Leggett &amp; Platt's net margin is impressive, surpassing industry averages. With a net margin of 2.88%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Leggett &amp; Platt's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.41%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Leggett &amp; Platt's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.68%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.78.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From Leggett & Platt Analyst Ratings: What You Need To Know

Goldman Sachs analyst Susan Maklari maintains Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) with a Neutral and lowers the price target from $20 to $14.

Goldman Sachs Maintains Neutral on Leggett & Platt, Lowers Price Target to $14

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the &#8220;Fear&#8221; zone on Wednesday.
U.S. stocks settled mixed on Wednesday, after the Federal Reserve announced its policy decision. The U.S. central bank opted to keep the federal funds rate unchanged at 5.25% to 5.5%, as widely expected. The Fed said it does not expect it will be appropriate to cut rates until it has gained greater confidence inflation is moving sustainably toward 2%.
On the economic data front, U.S. private employers added 192,000 new jobs during the month of April, compared to a revised 208,000 in March, topping market estimates of a 175,000 gain. The ISM manufacturing PMI declined to 49.2 in April from 50.3 a month ago.
All three major indices recorded losses in April, ending a streak of five consecutive months of gains.
Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) reported better-than-expected first-quarter financial results. Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) shares dipped around 27% after the company reported worse-than-expected first-quarter financial results. Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shares gained over 2% after the company reported upbeat results for its first quarter on Tuesday.
Most sectors on the S&amp;P 500 closed on a negative note, with energy and information technology stocks recording the biggest losses on Wednesday. However, communication services and utilities stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 87 points to 37,903.29 on Wednesday. The S&amp;P 500 fell 0.34% at 5,018.39, while the Nasdaq Composite declined 0.33% at 15,605.48 during Wednesday's session.
Investors are awaiting earnings results from Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>), ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) today.
At a current reading of 40.2, the index remained in the &#8220;Fear&#8221; zone on Wednesday, versus a prior reading of 39.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: <a href="https://www.benzinga.com/news/24/05/38550570/jim-cramer-these-airline-stocks-trade-wildly-edwards-lifesciences-at-the-right-level-to-buy">Jim Cramer: These Airline Stocks &#8216;Trade Wildly,&#8217; Edwards Lifesciences &#8216;At The Right Level To Buy&#8217;</a>

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%, as widely expected.
The Dow traded up 0.55% to 38,022.21 while the NASDAQ rose 0.19% to 15,687.08. The S&amp;P 500 also rose, gaining, 0.08% to 5,039.51.
Check This Out: <a href="https://www.benzinga.com/news/24/05/38546448/this-analyst-with-86-accuracy-rate-sees-more-than-24-upside-in-lattice-semiconductor-here-are-5-stoc">This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor &#8211; Here Are 5 Stock Picks For April From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Utilities shares rose by 1.2% on Wednesday.
In trading on Wednesday, energy shares fell by 1.6%.
Top Headline
Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) reported better-than-expected first-quarter financial results.
Pfizer reported first-quarter adjusted EPS of 82 cents, down 33% year over year, beating the consensus of 54 cents. The U.S. drugmaker reported sales of $14.9 billion, down 20%, beating the consensus of $14.2 billion.
The company expects adjusted EPS of $2.15-$2.35 in 2024 compared with a prior forecast of $2.05 to $2.25 and the consensus of $2.76.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) shares shot up 148% to $4.04. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8 after the close of markets.</li>
<li>Shares of TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) got a boost, surging 27% to $119.15 after the company raised its 2024 guidance.</li>
<li>Rocky Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) shares were also up, gaining 24% to $32.06 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares dropped 72% to $0.3164 after the company announced pricing of a $10 million upsized underwritten public offering.</li>
<li>Shares of CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) were down 35% to $10.02 after the company reported worse-than-expected first-quarter financial results. JP Morgan analyst Robbie Marcus downgraded the stock from Overweight to Neutral and lowered the price target from $36 to $13.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) was down, falling 27% to $13.12 after the company reported worse-than-expected first-quarter financial results. The company also reduced its dividend.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38549444/exxon-mobil-kimberly-clark-and-2-other-stocks-insiders-are-selling">Exxon Mobil, Kimberly-Clark And 2 Other Stocks Insiders Are Selling</a> 
Commodities In commodity news, oil traded down 3.3% to $79.23 while gold traded up 0.5% at $2,315.00.
Silver traded up 0.4% to $26.755 on Wednesday, while copper fell 0.4% to $4.5470.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.11%, while London's FTSE 100 fell 0.28%.
The S&amp;P Global UK manufacturing PMI was revised higher to 49.1 in April from a preliminary reading of 48.7, while Nationwide House Price Index increased 0.6% year-over-year in April.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 0.34%.
Japan's au Jibun Bank manufacturing PMI was revised lower to 49.6 in April compared to preliminary reading of 49.9.
Economics
<ul>
<li>U.S. mortgage applications declined by 2.3% from the prior week in the period ending April 26.</li>
<li>U.S. private employers added 192,000 new jobs during the month of April, compared to a revised 208,000 in March, topping market estimates of a 175,000 gain.</li>
<li>The S&amp;P Global manufacturing PMI declined to 50 in April versus 51.9 a month ago.</li>
<li>U.S. construction spending declined by 0.2% from the prior month in March.</li>
<li>The number of job openings fell by 325,000 from the prior month to 8.488 million in March.</li>
<li>The ISM manufacturing PMI declined to 49.2 in April from 50.3 a month ago.</li>
<li>U.S. crude oil inventories rose by 7.265 million barrels in the week ending April 26, compared to a 6.368 million barrel fall in the prior week.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38548319/amazon-to-rally-over-37-here-are-10-top-analyst-forecasts-for-wednesday">Amazon To Rally Over 37%? Here Are 10 Top Analyst Forecasts For Wednesday</a>

Eurozone

Commodities

Intraday Update

CETX

CTMX

CVRX

RCKY

TMDX

Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates

Shares of Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) fell sharply during Wednesday's session as the company reported first-quarter results and issued revenue <a href="https://www.benzinga.com/news/earnings/24/04/38534910/amd-investors-pull-back-after-modest-q1-beat-ceo-touts-ai-chip-ramp-up">guidance for the second quarter</a>.
AMD guided to second-quarter revenue of $5.7 billion plus or minus $300 million and a non-GAAP gross margin of about 53% against Street estimates of $5.7 billion in second-quarter revenue. Street expectations for fiscal year 2024 are for earnings of $3.40 per share and revenue of $24.13 billion, respectively, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Advanced Micro Devices shares dipped 6.9% to $147.44 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) shares jumped 97.5% to $3.2199. CytomX Therapeutics will report first quarter 2024 results and issue an initial CX-904 Phase 1a clinical data update on May 8.</li>
<li>IM Cannabis Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) gained 41.3% to $1.2150 after jumping around 54% on Tuesday.</li>
<li>Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) gained 39.5% to $0.1295. Shares of cannabis-related stocks traded higher following reports suggesting the DEA plans to reclassify cannabis as a less dangerous drug.</li>
<li>Getaround, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETR#NYSE">GETR</a>) rose 35% to $0.2741 after the company announced it secured up to $50 million in additional financing.</li>
<li>Rocky Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) gained 31.6% to $33.93 after the company reported better-than-expected quarterly financial results.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares climbed 28% to $7.72 after the company announced completion of its analysis to determine the effects of bioactivated PALI-2108 on TNF-α production in a whole blood assay.</li>
<li>TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) shares rose 28% to $120.26 after the company raised its 2024 guidance.</li>
<li>Surmodics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>) gained 27.2% to $32.69 following strong quarterly results.</li>
<li>DecisionPoint Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPSI#NASDAQ">DPSI</a>) rose 24.6% to $10.03 as the company agreed to go private in all-cash transaction.</li>
<li>CareDx, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) rose 23.4% to $9.59. CareDx is expected to report financial results for the first quarter 2024 after the closing bell on Thursday, May 9.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) jumped 23.2% to $176.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>TG Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) rose 21.7% to $16.64 following a first-quarter revenue beat and increased 2024 Briumvi US net product revenue outlook.</li>
<li>New York Community Bancorp, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) climbed 20% to $3.1887 following quarterly results.</li>
<li>Bio-Techne Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECH#NASDAQ">TECH</a>) jumped 20.1% to $75.89 following upbeat quarterly results.</li>
<li>Inari Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) shares gained 19.1% to $44.47 after the company reported better-than-expected first-quarter sales results and issued FY24 revenue guidance above estimates.</li>
<li>LendingClub Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) gained 18% to $8.87.</li>
<li>A10 Networks, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) gained 17.7% to $15.38 following better-than-expected quarterly results.</li>
<li>Pinterest, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) rose 17.5% to $39.29 following strong first-quarter earnings and upbeat second-quarter guidance.</li>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares climbed 17.2% to $81.66 after the company reported better-than-expected first-quarter financial results.</li>
<li>LendingClub Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) gained 17.2% to $8.82 following upbeat earnings.</li>
<li>UFP Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) jumped 13.8% to $234.34 following upbeat earnings.</li>
<li>Conduent Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNDT#NASDAQ">CNDT</a>) rose 13.7% to $3.58 after the company reported better-than-expected first-quarter results and issued strong FY24 guidance.</li>
<li>Stagwell Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STGW#NASDAQ">STGW</a>) gained 13.1% to $6.73 following upbeat earnings.</li>
<li>The Chefs&#8217; Warehouse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>) climbed 11.5% to $36.89 following strong quarterly earnings.</li>
<li>Garmin Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NASDAQ">GRMN</a>) rose 11% to $160.40 after the company reported better-than-expected first-quarter financial results and affirmed FY24 adjusted EPS and sales guidance, which is above estimates.</li>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) rose 9.9% to $1.5699 after the company announced a collaboration with FluGen for an intranasal flu vaccine.</li>
<li>Trinity Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRN#NYSE">TRN</a>) gained 9.4% to $28.48 following upbeat earnings.</li>
<li>Plutonian Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTN#NASDAQ">PLTN</a>) gained 6.8% to $9.48.</li>
<li>Lion Group Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares gained 6.5% to $0.5188 after the company reported a year-over-year increase in FY23 financial results.</li>
<li>Lemonade, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) shares gained 6% to $18.26 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance above estimates.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares fell 73.1% to $0.3054 after the company announced pricing of a $10 million upsized underwritten public offering.</li>
<li>Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) dipped 61.8% to $9.41.</li>
<li>CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) fell 40.2% to $9.27 after the company reported worse-than-expected first-quarter financial results. JP Morgan analyst Robbie Marcus downgraded the stock from Overweight to Neutral and lowered the price target from $36 to $13.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) fell 29.1% to $12.81 after the company reported worse-than-expected first-quarter financial results. The company also reduced its dividend.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) dipped 28.8% to $0.6052.</li>
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) fell 25.5% to $1.90</li>
<li>Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) dipped 25% to $11.16.</li>
<li>Visionary Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) declined 22.3% to $0.1883.</li>
<li>Astec Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTE#NASDAQ">ASTE</a>) fell 21.1% to $32.99 following downbeat quarterly results.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) dipped 19.4% to $54.55 following worse-than-expected first-quarter EPS and revenues.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares declined 15.9% to $721.99 following mixed third-quarter financial results.</li>
<li>Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) fell 15.8% to $74.54 following weaker-than-expected second-quarter earnings.</li>
<li>Ryerson Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYI#NYSE">RYI</a>) declined 15.1% to $24.25 after posting a loss for the first quarter.</li>
<li>DigitalBridge Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NASDAQ">DBRG</a>) fell 14.4% to $14.08 after the company reported first-quarter financial results.</li>
<li>Hillenbrand, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) dipped 14% to $41.04 after the company reported mixed second-quarter financial results and cut FY24 adjusted EPS guidance below estimates.</li>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) shares fell 13.7% to $92.01 after the company reported second-quarter financial results and issued third-quarter revenue guidance with the midpoint below estimates.</li>
<li>Sobr Safe Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares declined 12.2% to $0.2801.</li>
<li>SiteOne Landscape Supply, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SITE#NASDAQ">SITE</a>) fell 11.6% to $138.66 after the company reported mixed first-quarter financial results.</li>
<li>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) fell 11% to $16.84 following a first-quarter revenue miss and soft FY24 guidance.</li>
<li>O-I Glass, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) fell 10.5% to $13.38 after the company reported worse-than-expected first-quarter sales results and cut FY24 adjusted EPS guidance.</li>
<li>The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) fell 9.7% to $132.39 after the company reported third-quarter financial results and issued FY24 adjusted EPS guidance below estimates.</li>
<li>Global Payments Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) fell 9% to $111.68 after the company reported first-quarter financial results and issued guidance.</li>
<li>Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) dipped 8.8% to $66.59. A report earlier today indicated federal prosecutors are examining the company&#8217;s financial transactions.</li>
<li>The Carlyle Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) fell 8.2% to $41.10 after the company reported first-quarter financial results.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) shares declined 7.9% to $1.2801. Polestar delayed annual report due to accounting errors.</li>
<li>The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) fell 6.3% to $36.19 following mixed first-quarter results.</li>
<li>The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) fell 6% to $139.09 after the company reported worse-than-expected third-quarter sales results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38550761/how-to-earn-500-a-month-from-intel-stock-following-q1-earnings-report">How To Earn $500 A Month From Intel Stock Following Q1 Earnings Report</a>

Movers

AKAN

ASTE

ATEN

CDNA

CHEF

CNDT

DBRG

DPSI

GETR

GRMN

IMCC

LGHL

LMND

MNDR

NARI

NCLH

NYCB

PALI

PINS

PLTN

POAI

POWL

PSNY

ROOT

SBUX

SITE

SMCI

SOBR

SRDX

STGW

SWKS

TECH

TGTX

UFPT

XTIA

Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Rocky Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) stock rose 26.5% to $32.6 during Wednesday's regular session. The company's market cap stands at $241.8 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) shares rose 14.84% to $1.62. The company's market cap stands at $66.7 million. </li>
<li>Smart Share Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EM#NASDAQ">EM</a>) stock increased by 14.56% to $0.82. The company's market cap stands at $211.5 million. </li>
<li>NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares rose 12.71% to $5.32. The company's market cap stands at $11.1 billion. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) shares increased by 12.42% to $1.28. The market value of their outstanding shares is at $2.7 million. </li>
<li>OneSpaWorld Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSW#NASDAQ">OSW</a>) shares increased by 11.63% to $14.2. The company's market cap stands at $1.4 billion. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) shares declined by 27.9% to $13.03 during Wednesday's regular session. The company's market cap stands at $1.7 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Visionary Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) shares declined by 25.79% to $0.19. The company's market cap stands at $9.8 million. </li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares decreased by 20.24% to $2.38. The market value of their outstanding shares is at $146.6 million. </li>
<li>Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares decreased by 16.94% to $73.5. The company's market cap stands at $83.2 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Landsea Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) shares decreased by 14.07% to $9.93. The company's market cap stands at $358.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) stock decreased by 13.49% to $1.72. The company's market cap stands at $21.5 million. As per the news, the Q4 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GRWG

JWEL

LSEA

LVLU

VNCE

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Wednesday.
The Dow traded up 0.33% to 37,941.76 while the NASDAQ fell 0.35% to 15,603.45. The S&amp;P 500 also fell, dropping, 0.25% to 5,023.16.
Check This Out: <a href="https://www.benzinga.com/news/24/05/38546448/this-analyst-with-86-accuracy-rate-sees-more-than-24-upside-in-lattice-semiconductor-here-are-5-stoc">This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor &#8211; Here Are 5 Stock Picks For April From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Communication services shares rose by 1.1% on Wednesday.
In trading on Wednesday, energy shares fell by 1.3%.
Top Headline
The ISM manufacturing PMI declined to 49.2 in April from 50.3 a month ago.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) shares shot up 168% to $4.37. CytomX Therapeutics will report first quarter 2024 results and issue an initial CX-904 Phase 1a clinical data update on May 8.</li>
<li>Shares of TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) got a boost, surging 26% to $118.99 after the company raised its 2024 guidance.</li>
<li>Rocky Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) shares were also up, gaining 24% to $31.87 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares dropped 74% to $0.3010 after the company announced pricing of a $10 million upsized underwritten public offering.</li>
<li>Shares of CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) were down 42% to $8.95 after the company reported worse-than-expected first-quarter financial results. JP Morgan analyst Robbie Marcus downgraded the stock from Overweight to Neutral and lowered the price target from $36 to $13.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) was down, falling 30% to $12.57 after the company reported worse-than-expected first-quarter financial results. The company also reduced its dividend.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38549444/exxon-mobil-kimberly-clark-and-2-other-stocks-insiders-are-selling">Exxon Mobil, Kimberly-Clark And 2 Other Stocks Insiders Are Selling</a>
Commodities In commodity news, oil traded down 3.2% to $79.35 while gold traded up 0.3% at $2,310.70.
Silver traded up 0.1% to $26.67 on Wednesday, while copper fell 0.5% to $4.5405.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.14%, while London's FTSE 100 fell 0.34%.
The S&amp;P Global UK manufacturing PMI was revised higher to 49.1 in April from a preliminary reading of 48.7, while Nationwide House Price Index increased 0.6% year-over-year in April.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 0.34%.
Japan's au Jibun Bank manufacturing PMI was revised lower to 49.6 in April compared to preliminary reading of 49.9.
Economics
<ul>
<li>U.S. mortgage applications declined by 2.3% from the prior week in the period ending April 26.</li>
<li>U.S. private employers added 192,000 new jobs during the month of April, compared to a revised 208,000 in March, topping market estimates of a 175,000 gain.</li>
<li>The S&amp;P Global manufacturing PMI declined to 50 in April versus 51.9 a month ago.</li>
<li>U.S. construction spending declined by 0.2% from the prior month in March.</li>
<li>The number of job openings fell by 325,000 from the prior month to 8.488 million in March.</li>
<li>The ISM manufacturing PMI declined to 49.2 in April from 50.3 a month ago.</li>
<li>U.S. crude oil inventories rose by 7.265 million barrels in the week ending April 26, compared to a 6.368 million barrel fall in the prior week.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38548319/amazon-to-rally-over-37-here-are-10-top-analyst-forecasts-for-wednesday">Amazon To Rally Over 37%? Here Are 10 Top Analyst Forecasts For Wednesday</a>

Crude Oil Down 3%; ISM Manufacturing PMI Falls In April

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 0.1% on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.09% to 37,851.28 while the NASDAQ rose 0.04% to 15,663.99. The S&amp;P 500 also fell, dropping, 0.16% to 5,027.53.
Check This Out: T<a href="https://www.benzinga.com/news/24/05/38546448/this-analyst-with-86-accuracy-rate-sees-more-than-24-upside-in-lattice-semiconductor-here-are-5-stoc">his Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor &#8211; Here Are 5 Stock Picks For April From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Materials shares rose by 0.7% on Wednesday.
In trading on Wednesday, consumer staples shares fell by 0.7%.
Top Headline
Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) reported upbeat results for its first quarter on Tuesday, but issued weak sales forecast for the second quarter.
The company reported first-quarter net sales of $143.3 billion, up 13% year-over-year. The net sales total beat a Street consensus estimate of $142.5 billion, according to data from Benzinga Pro.
Amazon is guiding for second-quarter net sales to be in a range of $144 billion to $149 billion. The analyst consensus estimate is $150.1 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) shares shot up 73% to $2.82. CytomX Therapeutics will report first quarter 2024 results and issue an initial CX-904 Phase 1a clinical data update on May 8.</li>
<li>Shares of Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) got a boost, surging 45% to $0.1346. Shares of cannabis-related stocks traded higher following reports suggesting the DEA plans to reclassify cannabis as a less dangerous drug.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares were also up, gaining 46% to $8.78 after the company announced completion of its analysis to determine the effects of bioactivated PALI-2108 on TNF-α production in a whole blood assay.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares dropped 73% to $0.3030 after the company announced pricing of a $10 million upsized underwritten public offering.</li>
<li>Shares of CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) were down 42% to $9.05 after the company reported worse-than-expected first-quarter financial results. JP Morgan analyst Robbie Marcus downgraded the stock from Overweight to Neutral and lowered the price target from $36 to $13.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) was down, falling 39% to $11.06 after the company reported worse-than-expected first-quarter financial results. The company also reduced its dividend.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38549444/exxon-mobil-kimberly-clark-and-2-other-stocks-insiders-are-selling">Exxon Mobil, Kimberly-Clark And 2 Other Stocks Insiders Are Selling</a>
Commodities In commodity news, oil traded down 1.3% to $80.87 while gold traded up 0.1% at $2,303.70.
Silver traded up 0.3% to $26.735 on Wednesday, while copper fell 0.6% to $4.5355.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 slipped 0.1%, while London's FTSE 100 rose 0.1%.
The S&amp;P Global UK manufacturing PMI was revised higher to 49.1 in April from a preliminary reading of 48.7, while Nationwide House Price Index increased 0.6% year-over-year in April.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 0.34%.
Japan's au Jibun Bank manufacturing PMI was revised lower to 49.6 in April compared to preliminary reading of 49.9.
Economics
U.S. mortgage applications declined by 2.3% from the prior week in the period ending April 26.
U.S. private employers added 192,000 new jobs during the month of April, compared to a revised 208,000 in March, topping market estimates of a 175,000 gain.
Now Read This: <a href="https://www.benzinga.com/news/24/05/38548319/amazon-to-rally-over-37-here-are-10-top-analyst-forecasts-for-wednesday">Amazon To Rally Over 37%? Here Are 10 Top Analyst Forecasts For Wednesday</a>

US Stocks Mixed; Amazon Posts Upbeat Earnings

Dividend Income: Lanny's July 2024 Summary

Leggett & Platt declares $0.05 dividend

53 August Dividend Kings: Buy 7, Watch 9 More

2 Fallen Former Dividend Kings For A Small Cap Recovery Trade

2 Stocks To Consider For Income Reliability And Upside Potential

3M Company cut its dividend because of legal settlements, the divestment of the Healthcare segment into an independent company, Solventum, and the need to maintain financial flexibility. It is the third Dividend King to do so in 2024.

3M Company Dividend Cut

Stock Picks From Seeking Alpha's August 2024 New Analysts

Warning: LEG is at high risk of performing badly

Buy 7 September Dividend Kings, Watch 9 More

Piper Sandler analyst Peter Keith maintained a Sell rating on Leggett & Platt (LEG – Research Report) today and set a price target of $11.00. The c...

Piper Sandler Sticks to Their Sell Rating for Leggett & Platt (LEG)

AMNF

BRBOF

BRBOY

BTSG

BTSGU

CDUAF

CHGG

CLPR

CSCO

FLTLF

FRCOF

FRCOY

INTC

IREN

KVUE

LULU

MAIN

MANH

MGPI

MMDCF

MNMD

MSEX

NIOIF

NTAP

ORCL

PARA

REPYF

REPYY

ROAD

RTMVF

RTMVY

SOLV

SPHD

SWGAF

SWGAY

SWGNF

TPVG

TSX:AUM

UBSI

VEOEF

VEOEY

VGSH

Press Releases

LEGGETT & PLATT ANNOUNCES EXECUTIVE RETIREMENT AND APPOINTMENTS

LEGGETT & PLATT AMENDS CREDIT AGREEMENT

LEGGETT & PLATT ANNOUNCES 1Q 2024 EARNINGS CALL

Dividends

LEGGETT & PLATT REPORTS 1Q RESULTS, ANNOUNCES 2Q DIVIDEND OF $.05 AND UPDATES CAPITAL ALLOCATION PRIORITIES

LEGGETT & PLATT ANNOUNCES ANNUAL MEETING RESULTS

LEGGETT & PLATT APPOINTS KARL GLASSMAN AS PRESIDENT AND CEO

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

LEGGETT & PLATT ANNOUNCES 2Q 2024 EARNINGS CALL

LEGGETT & PLATT REPORTS 2Q RESULTS

LEGGETT & PLATT ANNOUNCES QUARTERLY DIVIDEND OF $.05

ADTN

ALTR

ATNI

BMRN

CLDT

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Leggett & Platt

Leggett & Platt (LEG) Forecast

Leggett & Platt (NYSE:LEG) Stock, Quote.Headers.trade-ideas